BIO-key International Inc... (BKYI)
BIO-key International Statistics
Share Statistics
BIO-key International has 5.81M shares outstanding. The number of shares has increased by 72.36% in one year.
| Shares Outstanding | 5.81M |
| Shares Change (YoY) | 72.36% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 4.16% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 6,807 |
| FTD / Avg. Volume | 2.2% |
Short Selling Information
The latest short interest is 54.29K, so 0.93% of the outstanding shares have been sold short.
| Short Interest | 54.29K |
| Short % of Shares Out | 0.93% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -52.12 and the forward PE ratio is null. BIO-key International's PEG ratio is 0.52.
| PE Ratio | -52.12 |
| Forward PE | n/a |
| PS Ratio | 32.31 |
| Forward PS | 0.5 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0.52 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for BIO-key International.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.41, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.41 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -1.27K |
| Debt / FCF | -0.03 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $2,439.02 |
| Profits Per Employee | $-1,512.2 |
| Employee Count | 41 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -55.03% in the last 52 weeks. The beta is 0.5, so BIO-key International's price volatility has been higher than the market average.
| Beta | 0.5 |
| 52-Week Price Change | -55.03% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 48.51 |
| Average Volume (20 Days) | 309,222 |
Income Statement
In the last 12 months, BIO-key International had revenue of 100K and earned -62K in profits. Earnings per share was -0.03.
| Revenue | 100K |
| Gross Profit | 81K |
| Operating Income | -58K |
| Net Income | -62K |
| EBITDA | -58K |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 437.6M in cash and 73.64M in debt, giving a net cash position of 363.97M.
| Cash & Cash Equivalents | 437.6M |
| Total Debt | 73.64M |
| Net Cash | 363.97M |
| Retained Earnings | -129.31B |
| Total Assets | 6.4M |
| Working Capital | -1.32M |
Cash Flow
In the last 12 months, operating cash flow was -2.91B and capital expenditures -13.05M, giving a free cash flow of -2.93B.
| Operating Cash Flow | -2.91B |
| Capital Expenditures | -13.05M |
| Free Cash Flow | -2.93B |
| FCF Per Share | -1548.99 |
Margins
Gross margin is 81%, with operating and profit margins of -58% and -62%.
| Gross Margin | 81% |
| Operating Margin | -58% |
| Pretax Margin | -62% |
| Profit Margin | -62% |
| EBITDA Margin | -58% |
| EBIT Margin | -58% |
| FCF Margin | -2927119% |
Dividends & Yields
BKYI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for BKYI.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 21, 2023. It was a backward split with a ratio of 1:18.
| Last Split Date | Dec 21, 2023 |
| Split Type | backward |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | -31.76 |
| Piotroski F-Score | 4 |